Global Growth/Differentiation Factor 8 Market Research Report 2012-2023

1 Market Overview

1.1 Objectives of Research

1.1.1 Definition

1.1.2 Specifications

1.2 Market Segment

1.2.1 by Type

1.2.1.1 OSX-200

1.2.1.2 SRK-015

1.2.1.3 ACE-2494

1.2.1.4 ACE-2798

1.2.1.5 BMS-986089

1.2.1.6 Others

1.2.2 by Application

1.2.2.1 Becker Muscular Dystrophy

1.2.2.2 Fibrosis

1.2.2.3 Myelofibrosis

1.2.2.4 Sickle Cell Disease

1.2.2.5 Others

1.2.3 by Regions

2 Industry Chain

2.1 Industry Chain Structure

2.2 Upstream

2.3 Market

2.3.1 SWOT

2.3.2 Dynamics

3 Environmental Analysis

3.1 Policy

3.2 Economic

3.3 Technology

3.4 Market Entry

4 Market Segmentation by Type

4.1 Market Size

4.1.1 OSX-200 Market, 2012-2017

4.1.2 SRK-015 Market, 2012-2017

4.1.3 ACE-2494 Market, 2012-2017

4.1.4 ACE-2798 Market, 2012-2017

4.1.5 BMS-986089 Market, 2012-2017

4.1.6 Others Market, 2012-2017

4.2 Market Forecast

4.2.1 OSX-200 Market Forecast, 2018-2023

4.2.2 SRK-015 Market Forecast, 2018-2023

4.2.3 ACE-2494 Market Forecast, 2018-2023

4.2.4 ACE-2798 Market Forecast, 2018-2023

4.2.5 BMS-986089 Market Forecast, 2018-2023

4.2.6 Others Market Forecast, 2018-2023

5 Market Segmentation by Application

5.1 Market Size

5.1.1 Becker Muscular Dystrophy Market, 2012-2017

5.1.2 Fibrosis Market, 2012-2017

5.1.3 Myelofibrosis Market, 2012-2017

5.1.4 Sickle Cell Disease Market, 2012-2017

5.1.5 Others Market, 2012-2017

5.2 Market Forecast

5.2.1 Becker Muscular Dystrophy Market Forecast, 2018-2023

5.2.2 Fibrosis Market Forecast, 2018-2023

5.2.3 Myelofibrosis Market Forecast, 2018-2023

5.2.4 Sickle Cell Disease Market Forecast, 2018-2023

5.2.5 Others Market Forecast, 2018-2023

6 Market Segmentation by Region

6.1 Market Size

6.1.1 Asia-Pacific

6.1.1.1 Asia-Pacific Market, 2012-2017

6.1.1.2 Asia-Pacific Market by Type

6.1.1.3 Asia-Pacific Market by Application

6.1.2 North America

6.1.2.1 North America Market, 2012-2017

6.1.2.2 North America Market by Type

6.1.2.3 North America Market by Application

6.1.3 Europe

6.1.3.1 Europe Market, 2012-2017

6.1.3.2 Europe Market by Type

6.1.3.3 Europe Market by Application

6.1.4 South America

6.1.4.1 South America Market, 2012-2017

6.1.4.2 South America Market by Type

6.1.4.3 South America Market by Application

6.1.5 Middle East & Africa

6.1.5.1 Middle East & Africa Market, 2012-2017

6.1.5.2 Middle East & Africa Market by Type

6.1.5.3 Middle East & Africa Market by Application

6.2 Market Forecast

6.2.1 Asia-Pacific Market Forecast, 2018-2023

6.2.2 North America Market Forecast, 2018-2023

6.2.3 Europe Market Forecast, 2018-2023

6.2.4 South America Market Forecast, 2018-2023

6.2.5 Middle East & Africa Market Forecast, 2018-2023

7 Market Competitive

7.1 Global Market by Vendors

7.2 Market Concentration

7.3 Price & Factors

7.4 Marketing Channel

8 Major Vendors

8.1 Acceleron Pharma, Inc.

8.1.2 Profile

8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.2 Atara Biotherapeutics, Inc.

8.2.1 Profile

8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.3 Bristol-Myers Squibb Company

8.3.1 Profile

8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.4 Eli Lilly and Company

8.4.1 Profile

8.4.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.5 Milo Biotechnology LLC

8.5.1 Profile

8.5.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.6 Pfizer Inc.

8.6.1 Profile

8.6.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.7 Regeneron Pharmaceuticals, Inc.

8.7.1 Profile

8.7.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.8 Sarepta Therapeutics, Inc.

8.8.1 Profile

8.8.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.9 Scholar Rock, Inc.

8.9.1 Profile

8.9.2 Business Performance (Sales Revenue, Cost, Gross Margin)

9 Conclusion

Table Products Segment of Growth/Differentiation Factor 8

Table OSX-200 Overview

Table SRK-015 Overview

Table ACE-2494 Overview

Table ACE-2798 Overview

Table BMS-986089 Overview

Table Others Overview

Table Global Growth/Differentiation Factor 8 Market by Type, 2011-2022 (USD Million)

Table Application Segment of Growth/Differentiation Factor 8

Table Becker Muscular Dystrophy Overview

Table Fibrosis Overview

Table Myelofibrosis Overview

Table Sickle Cell Disease Overview

Table Others Overview

Table Global Growth/Differentiation Factor 8 Market by Application, 2011-2022 (USD Million)

Table Global Growth/Differentiation Factor 8 Market by Region, 2011-2022 (USD Million)

Table Cost of Growth/Differentiation Factor 8

Table Market Dynamics

Table Policy of Growth/Differentiation Factor 8

Table GDP of Major Countries

Table OSX-200 CAGR by Revenue and Volume, 2012-2017

Table SRK-015 CAGR by Revenue and Volume, 2012-2017

Table ACE-2494 CAGR by Revenue and Volume, 2012-2017

Table ACE-2798 CAGR by Revenue and Volume, 2012-2017

Table BMS-986089 CAGR by Revenue and Volume, 2012-2017

Table Others CAGR by Revenue and Volume, 2012-2017

Table OSX-200 CAGR by Revenue and Volume, 2012-2022

Table SRK-015 CAGR by Revenue and Volume, 2012-2022

Table ACE-2494 CAGR by Revenue and Volume, 2012-2022

Table ACE-2798 CAGR by Revenue and Volume, 2012-2022

Table BMS-986089 CAGR by Revenue and Volume, 2012-2022

Table Others CAGR by Revenue and Volume, 2012-2022

Table Becker Muscular Dystrophy CAGR by Revenue and Volume, 2012-2017

Table Fibrosis CAGR by Revenue and Volume, 2012-2017

Table Myelofibrosis CAGR by Revenue and Volume, 2012-2017

Table Sickle Cell Disease CAGR by Revenue and Volume, 2012-2017

Table Others CAGR by Revenue and Volume, 2012-2017